High throughput screening of novel protein therapeutics

· 客户证明

High throughput screening of novel protein therapeutics

Integrating an INTEGRA VIAFLO 96 multichannel pipette into their high throughput expression facility has enabled Molecular Partners (Zurich, Switzerland) to streamline the discovery and development of a novel class of targeted protein therapeutics termed DARPins.

为该文章评分

验证码